Primary studies on the properties of trichosanthin after site-directed mutagenesis and PEGylation
AN Qun-Xing,LEI Ying-Feng,Jing Yang,LI Zhi-Dong,MU Shi-Jie,XU Zhi-Kai
DOI: https://doi.org/10.3321/j.issn:0251-0790.2009.08.021
2009-01-01
Abstract:To construct a PEGylated trichosanthin (TCS) mutein by site-directed PEGylahon and analyse its bioactivities, immunogenicity, acute toxicity and pharmacokinetics. By computer modeling, the site KR173-174 was identified as potential antigenic determinant of TCS. Then, a TCS mutelin namely TCSKR173-174CG was constructed by site-directed mutagenesis and expressed in E. coli BL21 (DE3). After that, the bloactivities, immunogenicity, acute toxicity and pharmacokinetics of the mutant TCS and PEGylated TCS were examined. It was shown that the bioactivities of the mutant TCS were similar to wild-type TCS (wTCS), but with much lower immunogenicity. The PEGylated TCS show a significant decrease in immunogenicity and acute toxicity, and a marked increase in plasma half-life when compared with unmodified TCS. But there is a problem of activity reduction. The site-directed mutagenesis and PEGylation of TCS provide a new approach for reconstructing TCS.